ES2049711T1 - Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de la cistinuria. - Google Patents

Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de la cistinuria.

Info

Publication number
ES2049711T1
ES2049711T1 ES93300048T ES93300048T ES2049711T1 ES 2049711 T1 ES2049711 T1 ES 2049711T1 ES 93300048 T ES93300048 T ES 93300048T ES 93300048 T ES93300048 T ES 93300048T ES 2049711 T1 ES2049711 T1 ES 2049711T1
Authority
ES
Spain
Prior art keywords
cystinuria
treatment
bucilamine
manufacture
medicinal product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES93300048T
Other languages
English (en)
Other versions
ES2049711T3 (es
Inventor
Hisashi Baba
Hideo Takashina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of ES2049711T1 publication Critical patent/ES2049711T1/es
Application granted granted Critical
Publication of ES2049711T3 publication Critical patent/ES2049711T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

EL BACILAMINO O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL MISMO, (POR EJEMPLO UNA SAL DE SODIO O DE POTASIO) SE USA PARA EL TRATAMIENTO Y/O PREVENCION DE LA CISTINURIA.
ES93300048T 1992-01-10 1993-01-06 Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de cistinuria. Expired - Lifetime ES2049711T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4040037A JP2814033B2 (ja) 1992-01-10 1992-01-10 シスチン尿症治療剤

Publications (2)

Publication Number Publication Date
ES2049711T1 true ES2049711T1 (es) 1994-05-01
ES2049711T3 ES2049711T3 (es) 1995-06-01

Family

ID=12569714

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93300048T Expired - Lifetime ES2049711T3 (es) 1992-01-10 1993-01-06 Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de cistinuria.

Country Status (5)

Country Link
US (1) US5266595A (es)
EP (1) EP0551180B1 (es)
JP (1) JP2814033B2 (es)
DE (2) DE69300037T2 (es)
ES (1) ES2049711T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670545A (en) * 1996-02-09 1997-09-23 Board Of Regents Of The University Of Colorado Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species
ATE311868T1 (de) 1999-06-21 2005-12-15 Santen Pharmaceutical Co Ltd Arzneimittel für die rheumatoide arthritis
US20060275279A1 (en) * 2005-06-06 2006-12-07 Rozzell J D Methods for dissolving cystine stones and reducing cystine in urine
CA2888647A1 (en) * 2012-11-20 2014-05-30 Revive Therapeutics Inc. The use of bucillamine in the treatment of gout
US20210154161A1 (en) * 2017-07-25 2021-05-27 Altibio, Inc. Modified-release bucillamine compositions, kits, and methods for treating cystinuria, arthritis, gout, and related disorders
EP4004541A1 (en) * 2019-07-26 2022-06-01 Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Ergothioneine, s-methyl-ergothioneine, and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS535112A (en) * 1976-03-08 1978-01-18 Santen Pharmaceutical Co Ltd New cysteine derivatives

Also Published As

Publication number Publication date
JPH05186341A (ja) 1993-07-27
EP0551180B1 (en) 1994-12-28
DE69300037T2 (de) 1995-06-29
US5266595A (en) 1993-11-30
JP2814033B2 (ja) 1998-10-22
DE551180T1 (de) 1994-02-03
EP0551180A1 (en) 1993-07-14
DE69300037D1 (de) 1995-02-09
ES2049711T3 (es) 1995-06-01

Similar Documents

Publication Publication Date Title
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ES2186787T3 (es) Utilizacion de ritonavir (abt-538) para mejorar la farmacocinetica de medicamentos metabolizados por el citocromo p450 en un metodo de tratamiento del sida.
MX9203444A (es) Medicamentos.
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
PT83872A (de) Arzneimittel
ES2058892T3 (es) Uso de omeprazol como agente antimicrobiano.
AR042345A2 (es) Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
ES2096455T3 (es) Aplicacion de la lamotrigina en el tratamiento del neurosida.
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
HU9501623D0 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an antidepressant drug
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
ES2049711T1 (es) Uso de bucilamina para la fabricacion de un medicamento para el tratamiento de la cistinuria.
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
AR035006A1 (es) Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento.
MX171542B (es) Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas
ES2101747T3 (es) Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1.
ES2072386T3 (es) Derivados del penciclovir para el tratamiento de las infecciones de hepatitis-b.
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
FR2632525B1 (fr) Application therapeutique de la myeloperoxydase humaine
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
AU580890B2 (en) P-acylaminobenzamides

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 551180

Country of ref document: ES